These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16956919)

  • 41. [New research results give hope. Causal therapy of Crohn disease in sight].
    MMW Fortschr Med; 2004 Apr; 146(14):42-3. PubMed ID: 15344754
    [No Abstract]   [Full Text] [Related]  

  • 42. [Medical treatment of Crohn's disease].
    Hiwatashi N
    Nihon Shokakibyo Gakkai Zasshi; 2000 Feb; 97(2):145-52. PubMed ID: 10707582
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acute episode].
    Schölmerich J;
    Z Gastroenterol; 2003 Jan; 41(1):27-30. PubMed ID: 12541170
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of inflammatory bowel disease.
    Botoman VA; Bonner GF; Botoman DA
    Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
    Siegmund B; Zeitz M
    Rocz Akad Med Bialymst; 2004; 49():22-30. PubMed ID: 15631310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycophenolate mofetil for treatment of active inflammatory bowel disease. Clinical and immunological studies.
    Neurath MF; Wanitschke R; Peters M; Hildner K; Tufan R; Meyer zum Büschenfelde KH; Schlaak JF
    Ann N Y Acad Sci; 1998 Nov; 859():315-8. PubMed ID: 9928412
    [No Abstract]   [Full Text] [Related]  

  • 47. Exploitation of the whole gut lavage technique for in vivo assessment of intestinal immunity and inflammation in inflammatory bowel disease.
    Ferguson A; Choudari CP; Mwantembe O; Handy L
    Adv Exp Med Biol; 1995; 371B():1257-60. PubMed ID: 7502795
    [No Abstract]   [Full Text] [Related]  

  • 48. [Can the postoperative relapse of Crohn disease be influenced?].
    Jussila A; Färkkilä M; Järvinen HJ
    Duodecim; 2001; 117(8):817-22; quiz 822, 857. PubMed ID: 12116447
    [No Abstract]   [Full Text] [Related]  

  • 49. [Drug therapy of Crohn disease].
    Niemelä S
    Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions.
    Dionne S; Ruemmele FM; Seidman EG
    Nestle Nutr Workshop Ser Clin Perform Programme; 1999; 2():41-57; discussion 58-61. PubMed ID: 11490627
    [No Abstract]   [Full Text] [Related]  

  • 51. [Physiological function of intestinal intraepithelial gamma-delta T lymphocytes].
    Nanno M; Ishikawa H
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():454-8. PubMed ID: 15861695
    [No Abstract]   [Full Text] [Related]  

  • 52. Severe adverse reactions to Infliximab therapy are common in young children with inflammatory bowel disease.
    Kolho KL; Ruuska T; Savilahti E
    Acta Paediatr; 2007 Jan; 96(1):128-30. PubMed ID: 17187619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The MMAS-8, a screening tool for determining nonadherent behavior, should not be dismissed in IBD.
    Trindade AJ; Tinsley A; Kornbluth A; Ullman TA
    Am J Gastroenterol; 2012 Jun; 107(6):951-2; author reply 952. PubMed ID: 22664851
    [No Abstract]   [Full Text] [Related]  

  • 54. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
    Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines.
    Ben-Horin S; Goldstein I; Fudim E; Picard O; Yerushalmi Z; Barshack I; Bank I; Goldschmid Y; Meir SB; Mayer L; Chowers Y
    Gut; 2009 Mar; 58(3):396-403. PubMed ID: 18832521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokines and mucosal inflammatory response in Crohn's disease.
    van Deventer SJ
    Eur J Surg; 1998 Dec; 164(12):897-901. PubMed ID: 10029384
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats.
    Prakash O; Medhi B; Saikia UN; Pandhi P
    Indian J Exp Biol; 2011 Sep; 49(9):672-8. PubMed ID: 21941940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatitis in inflammatory bowel diseases.
    Pitchumoni CS; Rubin A; Das K
    J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.